BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29483110)

  • 21. Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against
    Lee DG; Hwang YH; Park EJ; Kim JH; Ryoo SW
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681686
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial properties of basidiomycota macrofungi to
    Millar BC; Nelson D; Moore RE; Rao JR; Moore JE
    Int J Mycobacteriol; 2019; 8(1):93-97. PubMed ID: 30860186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison.
    Godbole AA; Ahmed W; Bhat RS; Bradley EK; Ekins S; Nagaraja V
    Biochem Biophys Res Commun; 2014 Apr; 446(4):916-20. PubMed ID: 24642256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
    [No Abstract]   [Full Text] [Related]  

  • 26. Synergistic Efficacy of β-Lactam Combinations against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979
    [No Abstract]   [Full Text] [Related]  

  • 27. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
    Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ahmad MN; Garg T; Singh S; Shukla R; Malik P; Krishnamurthy RV; Kaur P; Chopra S; Dasgupta A
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0056422. PubMed ID: 36445129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus
    Sarathy JP; Zimmerman MD; Gengenbacher M; Dartois V; Dick T
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0123722. PubMed ID: 36350151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.
    Kumar P; Chauhan V; Silva JRA; Lameira J; d'Andrea FB; Li SG; Ginell SL; Freundlich JS; Alves CN; Bailey S; Cohen KA; Lamichhane G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus.
    Kim TS; Choe JH; Kim YJ; Yang CS; Kwon HJ; Jeong J; Kim G; Park DE; Jo EK; Cho YL; Jang J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674049
    [No Abstract]   [Full Text] [Related]  

  • 32. TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.
    Sarathy JP; Ganapathy US; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlling Extra- and Intramacrophagic
    Viljoen A; Herrmann JL; Onajole OK; Stec J; Kozikowski AP; Kremer L
    Front Cell Infect Microbiol; 2017; 7():388. PubMed ID: 28920054
    [No Abstract]   [Full Text] [Related]  

  • 34. Nitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria.
    Santucci P; Johansen MD; Point V; Poncin I; Viljoen A; Cavalier JF; Kremer L; Canaan S
    Sci Rep; 2019 Jun; 9(1):8667. PubMed ID: 31209261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug Discovery.
    Richter A; Strauch A; Chao J; Ko M; Av-Gay Y
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 30012760
    [No Abstract]   [Full Text] [Related]  

  • 36. Thiostrepton: A Novel Therapeutic Drug Candidate for
    Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
    Kirkwood ZI; Millar BC; Downey DG; Moore JE
    Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.
    Rudra P; Hurst-Hess K; Lappierre P; Ghosh P
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifabutin Is Active against Mycobacterium abscessus in Mice.
    Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Screening of the MMV Pandemic Response Box Reveals Epetraborole as a New Potent Inhibitor against
    Kim T; Hanh BT; Heo B; Quang N; Park Y; Shin J; Jeon S; Park JW; Samby K; Jang J
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.